Cd136 Recombinant Antibody - High Quality Research Reagents Available

Are you in search of a high-quality Cd136 Recombinant Antibody? I understand the importance of reliable reagents in your research and development efforts. Our Cd136 Recombinant Antibody is designed for optimal performance in various applications, from western blotting to immunohistochemistry. With its excellent specificity and sensitivity, this antibody ensures accurate results that can enhance your experimental outcomes, At Alpha Lifetech Incorporation, we prioritize the needs of our B2B partners. This antibody helps streamline your workflows and supports your ongoing projects. I assure you that our product undergoes rigorous quality control protocols, providing you the confidence you need when making purchasing decisions, Whether you’re working in academia or industry, you’ll find that our Cd136 Recombinant Antibody meets stringent standards, making it an invaluable tool for your research. Don't miss out on the opportunity to elevate your projects with proven reagents. Let’s discuss how we can support your work effectively

Hot Selling Product

ALP64505-Recombinant Human CD24 Protein, mFc Tag

ALP64506-Recombinant Human Biotinylated CD28 Protein, Fc Tag, Avi Tag

ALP64507-Recombinant Rhesus Macaque CD47/MER6 Protein, His Tag, Flag Tag

ALP64508-Recombinant Human Siglec-10 Protein, Fc Tag

ALP64509-Recombinant Human Siglec-10 Protein, mFc Tag

ALP64517-Recombinant Human CD223/LAG3 Protein, His Tag, Avi Tag

How-To Guide Cd136 Recombinant Antibody Industry Leaders Supplies the World’s Top Brands

In the rapidly evolving landscape of biopharmaceutical research, the demand for high-quality recombinant antibodies has surged. This demand is particularly met by industry leaders like Alpha Lifetech Inc., a company founded by a dedicated team of scientists with extensive expertise in membrane protein production, Nanobody discovery, and monoclonal antibody development. With a robust portfolio comprising nearly 10,000 high-quality reagents, including spot membrane proteins, cytokines, and drug target antibodies, Alpha Lifetech stands at the forefront of delivering innovative solutions to scientific communities worldwide. Alpha Lifetech Inc. is committed to providing top-notch products that cater to the ever-growing needs of researchers and biopharmaceutical companies. Their recombinant antibodies, specifically Cd136, play a crucial role in various applications, including drug development and personalized medicine. By partnering with leading global brands, Alpha Lifetech ensures that their clients have access to premium-grade reagents that are vital in advancing their research endeavors. As we continue to face new challenges in therapeutic development, having a reliable supplier of quality antibodies becomes paramount. For global procurement managers and researchers, choosing Alpha Lifetech Inc. as a supplier means investing in quality, reliability, and innovation. The company’s unwavering focus on research and development guarantees a steady stream of high-quality products tailored to meet specific research needs. Whether it’s for developing therapeutic antibodies or conducting critical research in immunology, Alpha Lifetech stands ready to support the global scientific community with their unparalleled offerings. Trust in their expertise and discover how partnering with Alpha Lifetech can propel your research forward.

How-To Guide Cd136 Recombinant Antibody Industry Leaders Supplies the World’s Top Brands

Company Type	Location	Annual Revenue (in USD)	Employees	Focus Area
Biotech Company	USA	$500,000,000	250	Recombinant Antibodies
Pharmaceutical Company	Germany	$1,200,000,000	500	Therapeutic Antibodies
Research Institute	UK	$300,000,000	150	Antibody Development
Diagnostic Company	Canada	$450,000,000	200	Diagnostic Tests
Biopharmaceutical Firm	Japan	$900,000,000	350	Therapeutics & Diagnostics

Insider Tips For Cd136 Recombinant Antibody Is The Best Trusted by Pros

The chart above illustrates the global demand for recombinant antibodies from 2018 to 2023. As seen in the data, there has been a steady increase in demand over the years, reflecting the growing interest and reliance on these biotechnologically manufactured antibodies across various research and clinical applications. In 2018, the demand was around 40,000 units, and it is projected to reach approximately 120,000 units by 2023. This growth can be attributed to advances in biotechnology, increasing investment in research and development, and the ever-expanding range of applications for recombinant antibodies in immunology, diagnostics, and therapeutics. The rise in personalized medicine and targeted therapies is likely to further accelerate the adoption of recombinant antibodies, making them a vital component in modern medicine and research environments. As the industry evolves, it will be essential for suppliers to adapt to these trends and ensure they meet the rising demand effectively.